PDCD1 and neoplasm: The gut potential function of intestinal microbes as an immunemodulator (by increasing the anti-tumor effect and potentially reduce irAEs) is so considerable that some ongoing trials are investigating the possibility of combining them with anti PD-1/PD-L1 and anti-CTLA-4 drugs (21).